IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: MD-R-2024-11-27-97504 | Healthcare
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
In Vitro Diagnostics (IVD) Quality Control Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET
7.1 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 Bio-Rad Laboratories Inc.
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Randox Laboratories Ltd.
16.3 Thermo Fisher Scientific Inc.
16.4 Technopath Clinical Diagnostics.
16.5 Bio-Techne Corporation
16.6 Fortress Diagnostics.
16.7 Roche Diagnostics
16.8 Siemens Healthineers
16.9 Danaher Corporation
16.10 SeraCare Life Sciences Inc.
16.11 Abbott Laboratories Inc.
16.12 Sysmex Corporation
16.13 Ortho-Clinical
16.14 Helena Laboratories
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By Product TypeQuality Control Products
    o Serum/Plasma-Based Controls
    o Whole Blood-Based Controls
    o Urine Based Controls
Data Management Solutions
Quality Assurance Services
By Application
Immunochemistry/Immunoassay
Clinical Chemistry
Hematology
Molecular Diagnostics
Coagulation & Hemostatis
Microbiology
By Manufacturer
Third-Party Control Manufacturers
    o Independent Controls
    o Instrument-Specific Controls
Original Equipment Manufacturers
By End User
Clinical Laboratories
Hospitals
Academic & Research Institutes
Companies
Bio-Rad Laboratories Inc.
Randox Laboratories Ltd.
Thermo Fisher Scientific Inc.
Technopath Clinical Diagnostics.
Bio-Techne Corporation
Fortress Diagnostics.
Roche Diagnostics
Siemens Healthineers
Danaher Corporation
SeraCare Life Sciences Inc.
Abbott Laboratories Inc.
Sysmex Corporation
Ortho-Clinical
Helena Laboratories
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.